ChemoMetec Past Earnings Performance

Past criteria checks 2/6

ChemoMetec has been growing earnings at an average annual rate of 24.9%, while the Life Sciences industry saw earnings growing at 13.9% annually. Revenues have been growing at an average rate of 18.5% per year. ChemoMetec's return on equity is 24.1%, and it has net margins of 33.4%.

Key information

24.9%

Earnings growth rate

24.0%

EPS growth rate

Life Sciences Industry Growth36.9%
Revenue growth rate18.5%
Return on equity24.1%
Net Margin33.4%
Next Earnings Update05 Feb 2025

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How ChemoMetec makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BATS-CHIXE:CHEMMC Revenue, expenses and earnings (DKK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 244081361810
31 Mar 244051401760
31 Dec 234021441550
30 Sep 234231611500
30 Jun 234441791600
31 Mar 234531791660
31 Dec 224611801710
30 Sep 224451701660
30 Jun 224281591610
31 Mar 223931451470
31 Dec 213581311330
30 Sep 213201101250
30 Jun 21281881180
31 Mar 21262811080
31 Dec 2024374980
30 Sep 2022967980
30 Jun 2021459970
31 Mar 2020654990
31 Dec 19197481010
30 Sep 1918645980
30 Jun 1917642940
31 Mar 1915837860
31 Dec 1814133780
30 Sep 1812725740
30 Jun 1811318690
31 Mar 1810715690
31 Dec 1710213690
30 Sep 179610660
30 Jun 17907640
31 Mar 17886610
31 Dec 16855590
30 Sep 16858540
30 Jun 168510500
31 Mar 168011470
31 Dec 157512440
30 Sep 156810420
30 Jun 15618410
31 Mar 15565380
31 Dec 14513360
30 Sep 14482350
30 Jun 14451330
31 Mar 14441320
31 Dec 13431310

Quality Earnings: CHEMMC has a high level of non-cash earnings.

Growing Profit Margin: CHEMMC's current net profit margins (33.4%) are lower than last year (40.2%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: CHEMMC's earnings have grown significantly by 24.9% per year over the past 5 years.

Accelerating Growth: CHEMMC's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: CHEMMC had negative earnings growth (-23.7%) over the past year, making it difficult to compare to the Life Sciences industry average (5.4%).


Return on Equity

High ROE: CHEMMC's Return on Equity (24.1%) is considered high.


Return on Assets


Return on Capital Employed


Discover strong past performing companies